These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24982238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
    Terada N, Hamano N, Kim WJ, Hirai K, Nakajima T, Yamada H, Kawasaki H, Yamashita T, Kishi H, Nomura T, Numata T, Yoshie O, Konno A.
    Am J Respir Crit Care Med; 2001 Aug 15; 164(4):575-9. PubMed ID: 11520718
    [Abstract] [Full Text] [Related]

  • 6. Suppressive Activity of Quercetin on Periostin Functions In Vitro.
    Irie S, Kashiwabara M, Yamada A, Asano K.
    In Vivo; 2016 Aug 15; 30(1):17-25. PubMed ID: 26709124
    [Abstract] [Full Text] [Related]

  • 7. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J, Petering H, Höchstetter R, Kimmig D, Wells TN, Kapp A, Proudfoot AE.
    Eur J Immunol; 1997 Nov 15; 27(11):2892-8. PubMed ID: 9394815
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride.
    Nogaki T, Asano K, Furuta A, Kanai K, Suzaki I, Kanei A, Suzaki H.
    Asian Pac J Allergy Immunol; 2012 Jun 15; 30(2):139-45. PubMed ID: 22830293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
    Mochizuki Y, Furuta A, Furuya A, Kanai K, Asano K, Suzaki H.
    In Vivo; 2008 Jun 15; 22(1):13-20. PubMed ID: 18396776
    [Abstract] [Full Text] [Related]

  • 11. Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro.
    Asano K, Kanai K, Suzaki H.
    Arzneimittelforschung; 2004 Jun 15; 54(8):436-43. PubMed ID: 15460210
    [Abstract] [Full Text] [Related]

  • 12. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT.
    Am J Respir Cell Mol Biol; 2001 Dec 15; 25(6):707-16. PubMed ID: 11726396
    [Abstract] [Full Text] [Related]

  • 13. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
    Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y.
    Rhinology; 2007 Sep 15; 45(3):235-41. PubMed ID: 17956026
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
    Shin SH, Park JY, Jeon CH, Choi JK, Lee SH.
    Laryngoscope; 2000 Aug 15; 110(8):1353-7. PubMed ID: 10942140
    [Abstract] [Full Text] [Related]

  • 15. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
    Menzies-Gow A, Ying S, Phipps S, Kay AB.
    Clin Exp Allergy; 2004 Aug 15; 34(8):1276-82. PubMed ID: 15298570
    [Abstract] [Full Text] [Related]

  • 16. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
    Lee CF, Sun HL, Lu KH, Ku MS, Lue KH.
    Pediatr Allergy Immunol; 2009 Aug 15; 20(5):493-9. PubMed ID: 19175892
    [Abstract] [Full Text] [Related]

  • 17. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA.
    Clin Exp Allergy; 2004 Jun 15; 34(6):958-64. PubMed ID: 15196286
    [Abstract] [Full Text] [Related]

  • 18. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis.
    Mahmoud F, Arifhodzic N, Haines D, Novotney L.
    J Pharmacol Sci; 2008 Oct 15; 108(2):149-56. PubMed ID: 18946193
    [Abstract] [Full Text] [Related]

  • 19. Quantitative expression levels of regulated on activation, normal T cell expressed and secreted and eotaxin transcripts in toluene diisocyanate-induced allergic rats.
    Im GJ, Hwang CS, Jung HH.
    Acta Otolaryngol; 2005 Apr 15; 125(4):370-7. PubMed ID: 15823807
    [Abstract] [Full Text] [Related]

  • 20. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.
    Int Immunopharmacol; 2005 Dec 15; 5(13-14):1800-8. PubMed ID: 16275616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.